Raw data for single drug treatments pertaining to figures 1 and 2

In this study, we treated phylogenetically diverse Mycobacterium tuberculosis clinical strains to 65 unique drug combinations in two different host-like <i>in vitro</i> conditions. We observed a broad range of drug response phenotypes across the strains, with the most effective drug combinations varying greatly by strain and metabolic condition.